⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL94902 | 0.82 | — | — | |
| Hydrochloric Acid SCHEMBL1776088 | 0.80 | GDA (0.96) | — | |
| SCHEMBL21286900 | 0.75 | GDA (0.60) | — | |
| SCHEMBL3885477 | 0.75 | GDA (0.60) | — | |
| SCHEMBL9708864 | 0.75 | GDA (0.60) | — | |
| SCHEMBL2202786 | 0.75 | GDA (0.60) | — | |
| Phosphoric Acid SCHEMBL2779124 | 0.75 | GDA (0.85) | — | |
| SCHEMBL245 | 0.74 | KDM4E (0.59) | — | |
| SCHEMBL21621435 | 0.74 | — | — | |
| SCHEMBL13038780 | 0.73 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220340893-A1 | BI-FUNCTIONAL COMPLEXES AND METHODS FOR MAKING AND USING SUCH COMPLEXES | NUEVOLUTION A/S (DK) | 2022-10-27 | — | — | US | disclosed |
| CN-102850238-B | The manufacture method of N-(amino-1, the 2-dicyanoethenyl of 2-) carbonamidine | NIPPON SODA CO., LTD. (JP) | 2015-08-19 | — | — | CN | disclosed |
| US-20140309186-A1 | Metabolomics-Based Identification of Disease-Causing Agents | GEORGIA TECH RESEARCH CORPORATION | 2014-10-16 | — | — | US | disclosed |
| CN-102850238-A | Method for production of N-(2-amino-1,2-dicyanovinyl)imidates | NIPPON SODA CO | 2013-01-02 | — | — | CN | disclosed |
| CN-102850277-A | Method for production of aminoimidazole derivatives | NIPPON SODA CO | 2013-01-02 | — | — | CN | disclosed |
| EP-2426672-A1 | ANISOTROPIC CONDUCTIVE PARTICLES | Hitachi Chemical Company, Ltd. (JP) | 2012-03-07 | — | — | EP | disclosed |
| US-20110246081-A1 | Metabolomics-Based Identification of Disease-Causing Agents | GEORGIA TECH RESEARCH CORPORATION (US) | 2011-10-06 | — | — | US | disclosed |
| US-20110044943-A1 | Anti-Viral Compounds, Compositions, And Methods Of Use | GLAXOSMITHKLINE LLC | 2011-02-24 | — | — | US | disclosed |
| US-20090197880-A1 | ANTI-VIRAL COMPOUNDS, COMPOSITIONS, AND METHODS OF USE | GENELABS TECHNOLOGIES, INC. | 2009-08-06 | — | — | US | disclosed |
| US-20090197880-A1 | ANTI-VIRAL COMPOUNDS, COMPOSITIONS, AND METHODS OF USE | GENELABS TECHNOLOGIES, INC. | 2009-08-06 | — | — | US | disclosed |
| US-20090186358-A1 | Pathway Analysis of Cell Culture Phenotypes and Uses Thereof | WYETH (US) | 2009-07-23 | — | — | US | disclosed |
| WO-2009052186-A1 | METABOLOMICS-BASED IDENTIFICATION OF DISEASE-CAUSING AGENTS | GEORGIA TECH RESEARCH CORPORATION (US) | 2009-04-23 | — | — | WO | disclosed |
| WO-2009011787-A1 | ANTI-VIRAL COMPOUNDS, COMPOSITIONS, AND METHODS OF USE | GENELABS TECHNOLOGIES, INC. (US) | 2009-01-22 | — | — | WO | disclosed |
| US-5389661-A | Treats hypertension, heart failure, glaucoma and hyperaldosteronism | WARNER-LAMBERT COMPANY (US) | 1995-02-14 | — | — | US | disclosed |
| US-5322950-A | Treating hypertension, hyperaldosteronism, glaucoma, heart failure | WARNER-LAMBERT COMPANY (US) | 1994-06-21 | — | — | US | disclosed |
| EP-0116828-B1 | PROCESS FOR THE PREPARATION OF IMIDAZOLE-4,5-DICARBOXYLIC ACID | BASF Aktiengesellschaft (DE) | 1986-12-03 | — | — | EP | disclosed |
| US-4550176-A | Preparation of imidazole-4,5-dicarboxylic acid | BASF AKTIENGESELLSCHAFT (DE) | 1985-10-29 | — | — | US | disclosed |
| EP-0116828-A1 | Process for the preparation of imidazole-4,5-dicarboxylic acid | BASF Aktiengesellschaft (DE) | 1984-08-29 | — | — | EP | disclosed |